US 7,396,531 B2 · Preventive and therapeutic use of polypeptides from African Swine virus as vaccines

Abstract

The present invention relates to the use of selected polypeptides from African Swine virus for the prevention and therapy of African Swine infections as well as other infections, including immune deficiencies in mammals and humans.

Claims2

Dependent claims

An isolated oligopeptide according to SEQ ID NO:

Dependencies are inferred from the claim text.

Facts

Application

11/481,535Filed 5 Jul 2006

Published

US 2008/0008721 A110 Jan 2008

Granted

8 Jul 2008

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07K 14/005
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof: from viruses
C12N 7/00
Viruses
A61K 39/00
Medicinal preparations containing antigens or antibodies
C12N 2710/12022
Asfarviridae: new viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Preventive and therapeutic use of polypeptides from African Swine virus as vaccines

Life of this patent

Abstract

Claims2

Preventive and therapeutic use of polypeptides from African Swine virus as vaccines

Life of this patent

Abstract

Claims2